LSV Asset Management lowered its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 98.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 10,100 shares of the company’s stock after selling 604,680 shares during the period. LSV Asset Management’s holdings in Cardinal Health were worth $2,076,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently bought and sold shares of the company. Strategy Asset Managers LLC purchased a new stake in Cardinal Health in the 3rd quarter worth approximately $775,000. Mirae Asset Global Investments Co. Ltd. boosted its position in Cardinal Health by 15.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock worth $5,938,000 after purchasing an additional 5,030 shares in the last quarter. Versor Investments LP purchased a new stake in Cardinal Health in the 3rd quarter worth approximately $2,090,000. Machina Capital S.A.S. boosted its position in Cardinal Health by 248.0% in the 3rd quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock worth $4,246,000 after purchasing an additional 19,280 shares in the last quarter. Finally, Atle Fund Management AB lifted its position in shares of Cardinal Health by 13.1% during the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock valued at $4,755,000 after buying an additional 3,500 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Analyst Upgrades and Downgrades
CAH has been the subject of several recent research reports. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research note on Friday, May 1st. Mizuho increased their price objective on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research note on Friday, February 6th. Morgan Stanley increased their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Argus increased their price objective on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Finally, Citigroup reduced their price objective on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $241.80.
Cardinal Health Stock Performance
NYSE CAH opened at $199.92 on Thursday. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The company has a market cap of $46.82 billion, a P/E ratio of 30.57, a P/E/G ratio of 1.19 and a beta of 0.53. The business has a fifty day moving average price of $204.15 and a 200 day moving average price of $208.90.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same period last year, the company earned $2.35 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is 31.19%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
See Also
- Five stocks we like better than Cardinal Health
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
